As the COVID-19 pandemic persists, countries remain vigilant in their efforts to mitigate and contain the spread of the disease through various efforts such as contact tracing and vaccine distribution. These efforts by countries update the global community on how society is moving forward to mitigate the virus and bring us closer to normalcy.
In the UK, according to Aripaka (2021) on November 4, 2021, Britain had become the first country to approve the revolutionary COVID-19 antiviral pill that have been developed by Merck & Co Inc and Ridgeback Biotherapeutics. Britain’s Medicines and Healthcare Products Regulatory Agency had recommended the drug named Molnupiravir, for individuals with mild to moderate COVID-19 and have at least one of the following risk factors; obesity, older age diabetes and heart disease. Meanwhile, according to Picheta (2021), all adults in the UK will be able to get their COVID-19 booster vaccine just 3 months after their second dose. Today, the UK has inoculated 31% of its over-12 population.
In the US, according to Reuters (2021), Paxlovid, Pfizer’s antiviral drug, and the aforementioned Molnupiravir are currently being reviewed for commercial use and distribution. The country has agreed to procure 10 million courses of Pfizer’s drug and 3.1 million courses of Merck’s pill. Furthermore, 79% of Americans 12 years old or older have all received their first dose.
In the Philippines, according to Magsambol (2021), on November 17, 2021, the Philippines received its first shipment of Molnupiravir pills. These pills were imported to the Philippines through Compassionate Use Permits that were given to 31 hospitals. As of November 29, 2021, 35.7 million Filipinos have been vaccinated.
Countries will continue to take the right actions they feel is best to address the pandemic and mitigate the spread of the virus. As global citizens, it is best to remain vigilant and maintain health protocols during the time of the COVID-19 pandemic.